| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 50.1135 | 49 |
| GSM780708 | Untreated after 4 days (C2_1) | 52.9448 | 56 |
| GSM780709 | Untreated after 4 days (C3_1) | 56.4678 | 61 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.3954 | 50 |
| GSM780720 | Untreated after 4 days (C2_2) | 55.6655 | 60 |
| GSM780721 | Untreated after 4 days (C3_2) | 52.363 | 55 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.6873 | 53 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 51.9187 | 54 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.3373 | 42 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 57.9555 | 63 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 53.6502 | 57 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 50.8415 | 51 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.5895 | 50 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 50.7909 | 51 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.2121 | 38 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.179 | 42 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 49.2118 | 46 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 50.6616 | 50 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 50.9158 | 51 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.3013 | 46 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.8813 | 51 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 53.1663 | 56 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 51.7298 | 53 |